Clinical Trial

A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to assess the safety and tolerability of single and multiple ascending doses of INS1033 in healthy participants.
Trial Details
NCT Number NCT07765706
Lead Sponsor Insmed Incorporated
Conditions Healthy Volunteers
Enrollment 116 participants
Start Date 2026-08-25
Primary Completion 2027-03-22 (estimated)
Study Completion 2027-03-22 (estimated)
Updated on ClinicalTrials.gov 2026-08-14